Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methylphenidate + behavioral therapy
- Development stage
- Unknown
- Lead developer
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This intervention is a multi-modal treatment protocol developed by Florida International University for adolescents with Attention Deficit Hyperactivity Disorder (ADHD) who are at risk for substance use disorders. The protocol combines pharmacological treatment using Concerta (an extended-release formulation of methylphenidate) with behavioral interventions, including Parent Training (PT), Cognitive Behavioral Therapy (CBT), and a Brief Early Intervention (BEI). Methylphenidate acts as a central nervous system stimulant by blocking the reuptake of norepinephrine and dopamine. The behavioral components aim to improve self-regulation and family dynamics to mitigate the risk of substance abuse in this vulnerable population.
- Brand names
- Concerta
- Other names
- Brief Early InterventionParent TrainingCognitive Behavioral TherapyBEI+PT+CBT+Concerta
02
Targets
NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)
Beyond the preview
Go deeper on methylphenidate + behavioral therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methylphenidate + behavioral therapy.